Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New use for alpha blockers: benign prostatic hyperplasia

S J Hill1, S L Lawrence, H Lepor

  • 1Medical College of Wisconsin, Milwaukee.

American Family Physician
|June 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Northwestern Dental Association.

The Dental register·2021
Same author

Evaluating the impact of CPAP weaning procedures on total days on nasal CPAP: A retrospective chart review.

Journal of neonatal-perinatal medicine·2021
Same author

The effect of EMAT coil geometry on the Rayleigh wave frequency behaviour.

Ultrasonics·2019
Same author

Structure-based exploration and pharmacological evaluation of N-substituted piperidin-4-yl-methanamine CXCR4 chemokine receptor antagonists.

European journal of medicinal chemistry·2018
Same author

More inclusive bipolar mixed depression definition by permitting overlapping and non-overlapping mood elevation symptoms.

Acta psychiatrica Scandinavica·2016
Same author

More inclusive bipolar mixed depression definitions by requiring fewer non-overlapping mood elevation symptoms.

Acta psychiatrica Scandinavica·2016

Alpha 1-adrenergic blockers offer a viable alternative to surgery for benign prostatic hypertrophy symptoms. These alpha blockers provide significant relief for over half of patients, with careful monitoring for side effects.

Area of Science:

  • Urology
  • Pharmacology

Background:

  • Benign prostatic hypertrophy (BPH) is a common condition in aging men.
  • Symptomatic BPH significantly impacts quality of life.
  • Surgical intervention carries risks and may not be suitable for all patients.

Purpose of the Study:

  • To evaluate alpha 1-adrenergic blockers as a treatment for symptomatic benign prostatic hypertrophy.
  • To assess the efficacy and safety of alpha blockers as monotherapy and adjunct therapy.

Main Methods:

  • Review of treatment protocols for benign prostatic hypertrophy.
  • Analysis of patient outcomes with alpha 1-adrenergic blockers.
  • Monitoring for side effects and treatment adjustments.

Main Results:

Related Experiment Videos

  • Alpha 1-adrenergic blockers provide a reasonable alternative to surgery for symptomatic BPH.
  • Adjunctive use with finasteride may be beneficial.
  • Over 50% of patients experience objective and subjective symptomatic relief.
  • Pretreatment evaluation is crucial to rule out other causes of symptoms.

Conclusions:

  • Alpha 1-adrenergic blockers are effective in managing symptomatic BPH.
  • Careful patient monitoring and slow dosage titration are recommended.
  • Side effects can be managed by administration timing or drug discontinuation.